Publications by authors named "Christoph Baldow"

Claim this Profile
M
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation.
Elena Karg, Christoph Baldow, Thomas Zerjatke, Richard E Clark, Ingo Roeder

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo.
Sebastian Wagner, Christoph Baldow, Andrea Calabria, Laura Rudilosso, Pierangela Gallina

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to predict relapse in leukemia using time series data: A comparative in silico study.
Helene Hoffmann, Christoph Baldow, Thomas Zerjatke, Andrea Gottschalk, Sebastian Wagner

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.
Tom Hähnel, Christoph Baldow, Joëlle Guilhot, François Guilhot, Susanne Saussele

Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology.
Katja Hoffmann, Katja Cazemier, Christoph Baldow, Silvio Schuster, Yuri Kheifetz

BMC Med Inform Decis Mak· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data.
Artur C Fassoni, Christoph Baldow, Ingo Roeder, Ingmar Glauche

Haematologica· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative prediction of long-term molecular response in TKI-treated CML - Lessons from an imatinib versus dasatinib comparison.
Ingmar Glauche, Matthias Kuhn, Christoph Baldow, Philipp Schulze, Tino Rothe

Sci Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAGPIE: Simplifying access and execution of computational models in the life sciences.
Christoph Baldow, Sebastian Salentin, Michael Schroeder, Ingo Roeder, Ingmar Glauche

PLoS Comput Biol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia.
Christoph Baldow, Lars Thielecke, Ingmar Glauche

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.
Rick Proschmann, Christoph Baldow, Tino Rothe, Meinolf Suttorp, Christian Thiede

Haematologica· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug target prioritization by perturbed gene expression and network information.
Zerrin Isik, Christoph Baldow, Carlo Vittorio Cannistraci, Michael Schroeder

Sci Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis